Randox Health partners with Roadchef Motorway Services to provide 20+ Covid Test Kit Dropboxes across the UK
Randox Health partners with Roadchef Motorway Services to provide 20+ Covid Test Kit Dropboxes across the UK
10 June 2021: Randox Health partners with Roadchef Motorway Services to provide 20+ Covid Test Kit Dropboxes across the UK
Randox Health, the UK’s largest Covid-19 PCR testing provider, is today pleased to announce a partnership with Roadchef Motorway Services, to expand its Covid-19 test kit dropbox network by an additional 20 sites across the UK.
Bringing the diagnostics company’s list of dropbox locations to now more than 100, the expansion comes as the resumption of international travel has increased the demand for Randox’s Covid-19 pre departure, day 2, day 8 and day 5 (test to release) testing services.
New Randox dropboxes have been installed at Roadchef sites including Durham, Chester, Cumbria, Swansea, Somerset and Kent.
Randox Business Development Manager Damian Milligan said;
“As we continue to invest in our testing capacity, customer support services, and logistics, we are pleased to partner with Roadchef Motorway Services to expand our UK Dropbox locations, offering a reliable and efficient way of returning your Covid-19 testing kit to our laboratories for testing.
“As our own independently-run private courier service, the Randox Dropbox service allows us to track delivery of your sample right through from drop-off to arrival at the lab, providing prompt delivery and next day results, to help reassure our customers that they will receive their results in time and their travel will go to plan.”
Roadchef Commercial Director Tracy Baitup commented;
“We welcome the opportunity to work alongside Randox, as the UK’s largest Covid-19 PCR testing provider, by providing our Roadchef Motorway Service locations as dropbox sites, to make the return of Covid-19 testing kits as easy as possible for those wishing to travel.
“Randox has played a key role in the global fight against Covid-19 since the outbreak of the pandemic last year and we are proud to be able to support their endeavours to facilitate international travel when it is safe to do so.”
Randox, with almost 40 years of international diagnostics experience, and a Covid-19 testing capacity of over 500,000 tests per day, is the largest Covid-19 laboratory in Europe. Having processed over 13 million tests to date, the company has proven testing capability, well-established logistics and dedicated customer support services, making it strongly placed to support the return to international travel.
For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or 0800 2545 201.
For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Belfast City Airport Announces Covid Testing Centre with Randox
Belfast City Airport Announces Covid Testing Centre with Randox
29 March 2021
Belfast City Airport Announces Covid Testing Centre with Randox
Belfast City Airport has announced an onsite covid testing centre in partnership with leading global diagnostics firm, Randox, in preparation for the return of its international flights in the coming months.
The centre will offer both PCR tests and antigen (lateral flow) tests and will give passengers access to quick and safe testing.
Judith Davis, Airport Operations Manager at Belfast City Airport, said:
“The PCR and antigen tests are a current requirement for passengers heading to the Netherlands, and with our KLM flights due to recommence over the next month, it is imperative that we have the testing facilities in place to enable those travelling for essential reasons to be able to do so in a convenient manner.
“The testing facilities will also help with forward planning for those who are connecting through major hub airports, such as Manchester and London Heathrow, or travelling to sunshine destinations with our new airline partner, Ryanair, allowing them to take the test before they leave Northern Ireland.”
Belfast City Airport was recently the first airport in Northern Ireland to achieve the ACI’s Airport Health Accreditation for its extensive and thorough health and safety measures, such as sanitising stations throughout the terminal and requiring anyone entering to wear a face covering.
“The safety of our passengers and staff is at the forefront of our operations and those travelling to the Airport can be reassured that stringent measures are in place” Judith concluded.
David Adamson, Regional Manager at Randox Laboratories, said:
“Along the roadmap out of lockdown, testing will remain a key part of the response to COVID-19 – not only to identify cases and prevent further spread, but also to assist with a return to social and economic normality. The Randox Health Travel Centre at Belfast City Airport, providing accurate and cost-effective antigen and gold standard PCR testing, is another positive step towards the normalization of travel.
“We are pleased to be working with the airport to support their enormous efforts to restore public confidence in international travel and to get people back in the air again if and when they are required to do so.”
Work for the test centre is already underway, with H&J Martin Asset Management Services completing the fit out to include a resting area for passengers who have taken their test, and is expected to be completed over the coming weeks.
For further information please contact Amy Millar in the Randox Public Relations team; amy.millar@randox.com or 028 9442 2413
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour
Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour
03 March 2021
Randox launches COVID-19 Testing Drive-Through at Dun Laoghaire Harbour
A €99 Express COVID-19 Testing Service launches this week in a new Drive-Through Testing Centre at Dun Laoghaire Harbour.
The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, utilises a robust and reliable method of testing known as PCR, which is currently the only method of COVID-19 testing recognised and approved by every country worldwide.
The launch of the Dun Laoghaire Harbour Drive-Through, which offers rapid next day delivery of results, can be used for pre-departure screening, on-arrival testing to reduce quarantine timeframes, or simply for peace of mind.
Sophie Boyd, Project Manager for the Randox COVID-19 Testing Service, explained;
“In addition to our Travel Centres in Dublin, Limerick, Sligo and Galway, we are pleased to open our new Drive-Through testing service in Dun Laoghaire, to serve South County Dublin with our accurate and cost-effective COVID-19 test.
“Whilst restrictions and guidance during the pandemic continue to evolve, testing will remain a key part of the response to COVID-19 – not only to identify outbreaks, isolate cases and prevent further spread, but also to assist with a return to social and economic normality.”
Ireland is currently part of the EU ‘traffic lights’ system which coordinates international travel, meaning that anyone leaving Ireland, currently orange on the traffic light scale, can avoid quarantine on arrival if they obtain a negative PCR test result before departure.
Those arriving in Ireland – depending on their departure country – may be able to reduce their on-arrival quarantine timeframe by taking a COVID-19 test no less than 5 days after arrival.
Sophie continued;
“The Randox Health COVID-19 testing drive-through at Dun Laoghaire Harbour is another positive step towards the normalization of travel and other social activities, for the residents of Dun Laoghaire Rathdown and across South County Dublin.
“Anyone who is interested in booking a test can do so at the Randox Health booking website, and will have their results returned to them the next day.”
The Randox €99 Express COVID-19 Testing Service is open to all asymptomatic individuals and operates from the Randox Health Drive-Through at Dun Laoghaire Harbour.
Randox Health PCR Testing is also available at Terminal 2 at Dublin Airport, and in Leopardstown Dublin, Limerick, Sligo, Cork and Galway.
Visit booking.randox.ie to book your appointment.
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
COVID-19 Antigen Testing launched at Dublin Airport
COVID-19 Antigen Testing Service launched at Dublin Airport
22 February 2021
Travelling to a country that requires antigen testing?
Antigen Testing is the fastest and cheapest of all lab tests for COVID-19 and is now available at our Dublin Travel Centre for just €49. Testing is conducted using a nose and throat (nasopharyngeal) swab with your results available within 1 hour.
Sometimes called a ‘lateral flow test’, it will reveal if a person is currently infected with a pathogen such as SARS-CoV-2 – the virus that causes COVID-19. Unlike a PCR test (which detects the presence of genetic material) antigen tests detect proteins or glycans, such as spike proteins found on the surface of the COVID-19 virus.
Paul Turnbull, Randox Global Business Manager says;
“When it comes to travel, we started to see more and more countries across Europe state that they would only accept a negative PCR result and that has remained the case, as countries only want the most sensitive technology. Some countries however, such as the Netherlands, Germany & Sweden, require antigen testing as a secondary test before entry.”
Antigens remain in the body during infection and disappear once the COVID-19 infection has gone, so testing for antigens can identify those who whilst asymptomatic, are currently infected with, and could still be spreading the virus. It is thought that around 1 in 3 people with COVID-19 do not have symptoms, so a test that rapidly detects these otherwise hidden cases is a very useful additional tool for tackling the virus.
It is important to note that no test is 100% accurate and all tests have limitations. The preferred testing for COVID-19 is still the gold standard PCR testing due to its high sensitivity methodology. PCR testing requires samples to be sent back to our COVID-19 laboratory in County Antrim, which is why it can take up to 24hours to receive results for a PCR test, as opposed to 1 hour for antigen testing.
The Randox Health Dublin Airport Testing Centre offers both PCR and Antigen testing for travel and peace of mind.
Before booking an antigen testing appointment please confirm with your destination that this method is accepted as a means for entry. If flying the same day, please book your test 4 hours before your flight departure time.
Visit booking.randox.ie to book your appointment.
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Biotin supplementation interference in health testing
12 February 2021
Biotin supplementation interference in health testing
How much do you know about Biotin? Commonly known as Vitamin B7, Biotin is taken by as many as 20% of people, including high profile celebrities like Kylie Jenner, Kim Kardashian and Vanessa Hudgens, for its hair and nail-strengthening properties.
If you take biotin supplements, it is important to know the effects it can have on particular blood tests, should you visit your GP or local hospital.
Whilst there are various diagnostic health tests out there, including fertility hormone tests, prostate tests, and tests for troponin – a marker released into the blood during a heart attack – that are known to be affected by elevated levels of biotin, there are other tests available, including those provided by Randox, that are not impacted.
The reason that so many non-Randox tests are impacted by biotin is that biotin is widely used throughout the biotechnology industry in the development of diagnostic tests.
ELISA tests in particular (tests that measure the reaction of antibodies to identify a substance) often make use of antibodies labelled with biotin, to detect toxins or other foreign substances within the body.
In most instances, the biotin will bind to a protein called streptavidin. This bonding is the strongest non-covalent biological interaction known, and is therefore particularly useful in binding antibodies within diagnostic tests.
But with more and more people exceeding the recommended daily dosage for biotin (30 micrograms) by taking up to 10,000 micrograms of biotin in supplements marketed for beauty reasons, many diagnostic tests are being measured inaccurately. Excess biotin in the blood can block the binding of biotin-labelled antibodies to streptavidin within the tests, and the substance being tested won’t be measured accurately.
Laboratory professionals have known about this potential problem for some time. In late November 2017, the FDA (Food and Drug Administration) published a safety notice to make the public and healthcare practitioners more aware that biotin can “significantly interfere with certain lab tests and cause incorrect test results.”
The FDA even reported on one particular case in which a patient died following falsely low troponin (marker of a heart attack) results when the troponin test used was known to have biotin interference. Biotin supplements masked the true diagnosis of a heart attack.
Many patients taking biotin supplements have also been misdiagnosed with a condition called Graves’ disease, an autoimmune condition characterised by an overactive thyroid. In these cases, biotin supplementation led to falsely low levels of thyroid stimulating hormones, and falsely high levels of other thyroid hormones. This particular profile of hormones led to a Graves’ disease diagnosis, in spite of a lack of symptoms, which in Graves’ disease would usually include muscle weakness, a quickened heartbeat, sleeping problems, diarrhoea, weight loss and poor tolerance of heat.
In pregnant women, tests that are impacted by biotin interference may produce falsely low results of beta HCG, more commonly known as the ‘pregnancy hormone’ as it released by the placenta after conception. With low levels of beta HCG, and therefore no confirmation of pregnancy, pregnant women could be exposed to X-rays and CT scans that may harm the developing foetus.
So, what can be done? Suggestions have been made that patients taking biotin supplements should be made to wait before any diagnostic testing is conducted, so that the biotin clears from their system.
But this “Wait and Watch” approach certainly would not work in emergencies. In the case of a heart attack, testing must be conducted as soon as possible to allow for diagnosis, immediate medical intervention and follow-up testing.
At Randox, we are convinced that the risk of analytic interference by biotin supplementation is a serious problem that needs to be more widely recognised and promptly addressed.
In the GP setting, general practitioners must ask their patients if they are taking any biotin supplements and inform the testing laboratory if interference from biotin is a possibility. They should also consider that lab results not matching with a patient’s signs and symptoms may be caused by biotin interference.
In the acute care setting however, it is imperative that biotin technology is not used in diagnostic testing to protect patients from misdiagnosis and subsequently, further health problems.
This is why Randox’s patented Biochip Array Technology does not use biotin technology in its development. This revolutionary methodology, free from Biotin-Streptavidin is not impacted by elevated levels of biotin from supplementation in the same way as Biotin-Streptavidin tests.
So if you have been taking supplements for hair or nail growth, to ease symptoms associated with Multiple Sclerosis, for epilepsy or for a range of other health conditions, and your diagnostic testing has been conducted using Randox Biochip Array Technology, you can rest assured of true, accurate, and reliable results.
Randox Biochip Array Technology is interference-proof.
For further information on the Randox Biochip, visit https://www.randox.com/multiplex-testing/
For any additional questions, please contact Randox PR by email: randoxpr@randox.com or by phoning 028 9442 2413
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox launches new COVID-19 testing facility at Heathrow Airport
Randox launches new COVID-19 testing facility at Heathrow Airport
27 January 2021: Randox launches new COVID-19 testing facility at Heathrow Airport
Global healthcare diagnostics company Randox Health has announced a new COVID-19 testing facility at Heathrow Airport.
The service from Randox, which is the largest COVID-19 testing provider in the UK and Ireland, and a partner in the UK Government’s National COVID-19 Testing Programme, uses gold standard PCR technology to generate results in 1 – 3 hours.
The laboratory is capable of processing up to 1000 samples per day, for both fit to fly and test to release, which allows individuals in England returning home from international travel to stop self-isolating if they get a negative test result after 5 days.
Dr Peter FitzGerald, Randox Founder and Managing Director commented;
“We continue to expand our portfolio of bespoke testing products and services, and our new testing facility at Heathrow Airport brings us one step closer to a timely return to a more normal society.
“It’s great to be able to provide our fit to fly and test to release services to the airport and help support their enormous efforts to restore public confidence in international travel and get people back in the air again.”
The Randox testing facility at Heathrow Airport runs in partnership with Doctap who provide a team of certified Sample Collection Officers to perform the swabbing on site.
A Laboratory Technician subsequently expedites the sample and reports the results, meaning that a fit to fly or test to release certificate that would normally take up to 48 hours now takes as little as 1 hour, and no longer than 3 hours to deliver a certificate back to a customer.
To book a test please visit Doctap.co.uk/randox or check out our London PCR Travel Test Sites here.
For further information on the Mobile Testing Laboratory please email mobiletesting@randox.com
Randox Health offers a range of COVID-19 testing services for fit to fly, test to release, workplace testing or simply for peace of mind.
Order a home sample collection kit, book an appointment at a Randox Health Travel Centre (available in the UK and Ireland) or visit a Randox Mobile Laboratory (located at Heathrow and Liverpool Airports).
COVID-19 antibody testing is available in Randox Health Clinics.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
COVID-19 Testing Partnership with Belfast International Airport
COVID-19 Testing Partnership with Belfast International Airport
12 January 2021: COVID-19 Testing Partnership with Belfast International Airport
Global diagnostics firm Randox is working in collaboration with Belfast International Airport, to provide quick and affordable tests for passengers.
A new walk in testing facility has been launched at the airport, providing rapid PCR tests for those who require a negative test before travelling on any essential journeys.
The newly formed service will provide passengers with a cost-effective, reliable and convenient COVID-19 testing service prior to their travels.
Graham Keddie, Managing Director at Belfast International Airport said:
“Many destinations now require passengers, who have to travel for essential reasons, to have a negative PCR COVID-19 test no more than 72 hours before arrival. It is essential that we are able to introduce these measures as testing will help protect travellers and staff, and provide an increased level of confidence for those travelling when current lockdown restrictions ease.
“In the long run it should help assist in the recovery of the aviation and travel sector, however it is only a start and we need more to be done in terms of both the vaccine and testing.”
“Swabs are administered by trained sample collection officers which decreases the likelihood of an inconclusive result. Tests are then conducted by Randox scientists at a state-of-the-art testing laboratory within easy reach of the airport, ensuring the price is kept to a minimum and the results can be turned around quickly.
“We already have a close working relationship with Randox and we are delighted to partner with them on this important development for the travel industry.”
The new COVID-19 facility on site at Belfast International Airport provides a convenient location for passengers right across Northern Ireland, with free onsite parking available. Passengers can receive their certified results next day, which if negative, allow them to travel to their required destination.
Sophie Boyd, Project Manager for the Randox Express COVID-19 Testing Service, said:
“We are proud to be working with Belfast International Airport to make COVID-19 testing accessible, affordable and reliable for all travellers who need to make essential trips.
“We have worked hard to ensure the PCR test is as easy as possible for passengers. People can simply visit the airport website to book a test at a date and time to suit. They can then arrive for their test and receive their results the next day via email.
“It’s great to be able to provide this service to the airport and help support them in getting people back in the air when they are able to do so.”
This new testing provision will strengthen the health measures already in place at the airport in line with the international campaign “Protecting each other” developed and promoted by VINCI Airports for all the airports in its network worldwide.
Based on hygiene recommendations issued by the World Health Organization (WHO) and the International Civil Aviation Organization (ICAO), this campaign helped improve the cleaning and disinfection protocols, physical distancing, staff protection and passenger communications since the start of the COVID-19 pandemic.
The COVID-19 testing from Randox is available to book now and passengers will be able to attend a Randox Testing facility at the airport, or at a Randox Health Clinic in either Crumlin or Holywood. The price is £99.
To book a test with Randox please visit booking.randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox extends Grand National Festival Sponsorship for a further five years
Randox extends Grand National Festival Sponsorship for a further five years
22 December 2020: Randox extends Grand National Festival Sponsorship for a further five years
Randox has reached agreement with The Jockey Club for a five-year extension to its sponsorship of the world’s greatest steeplechase, the Grand National, and the three-day Grand National Festival staged at Aintree Racecourse.
The new agreement will run from 2022-2026, following on from the existing five-year deal which runs until next year. This ten-year sponsorship will be the second-longest partnership in the history of the Grand National.
As well as retaining headline naming rights for the three-day Grand National Festival, Randox will continue to sponsor all three races over the iconic Grand National fences; the Randox Foxhunters Chase on Liverpool’s NHS Day, the Randox Topham Chase on Ladies Day, and the iconic Randox Grand National on Grand National Day itself.
As the largest healthcare diagnostics company from the UK and Ireland, Randox undertakes research, development, manufacture and distribution of innovative laboratory tests and analysers. In 2019 Randox manufactured more than 4 billion tests and was active in 145 countries. The company employs more than 2,000 staff, including more than 450 research scientists and engineers, with key facilities located in Co Antrim and Co Donegal.
Randox focuses on the provision of comprehensive, accurate and timely testing in order to identify risk to health, improve clinical diagnoses and promote preventative healthcare; aiming to achieve better healthcare outcomes whilst reducing the burden on clinical services.
In early 2020 Randox recognised the threat from COVID-19 and, based on almost 40 years of diagnostic experience, quickly developed a test to accurately identify the virus. Testing at scale commenced within weeks to support both the UK’s National Testing Programme and private clients.
In March 2020, the company was processing 150 COVID-19 tests a day, but through investment and the enormous effort of its staff, Randox has been able to boost its laboratory testing capacity to process 90,000 COVID-19 samples per day for the UK Government’s National COVID-19 Testing Programme, making it the most productive laboratory in the UK and Ireland, and amongst the largest in Europe. It anticipates this climbing to 100,000 daily tests.
Dr. Peter FitzGerald CBE, Founder and Managing Director of Randox, said:
“We have thoroughly enjoyed working with The Jockey Club’s team at Aintree and look forward to another successful five years, when we are once again able to come together to celebrate the Randox Grand National.”
“This terrible pandemic has increased understanding of the importance of diagnostics and testing across our society. As a company founded with the ultimate aim of saving lives, we will work hard to convert that better understanding into the improvement of people’s health in the future.”
Noting how the Grand National will now be known as the Randox Grand National from 2021 with ‘Health’ being removed from the name, Dr. FitzGerald, adds:
“2020 has been a year of massive change and Randox has been at the forefront of countering the greatest pandemic to sweep these islands in 100 years. As a result, we are comfortable that our core company name is now synonymous with ‘health’ so are very happy to combine with Aintree to rebrand the world’s greatest steeplechase as, more succinctly, ‘the Randox Grand National’.
“We are excited for this new era of our partnership, of horse racing, and of society – in which COVID has taught us to appreciate the important things in life – our friends, our family, and our health. We very much look forward to the next five years.”
With around 9.5 million people tuning in each year in the UK through broadcast partners ITV, The Randox Grand National attracts one of the largest live TV audiences in sport. In 2017, ITV won a BAFTA for their exceptional coverage of the world’s greatest steeplechase. Worldwide the event attracts an estimated television audience of around 600 million.
Randox also continues as the Official Healthcare Partner of The Jockey Club. Founded in 1750 and today British Racing’s largest commercial group, The Jockey Club runs many of the sport’s most iconic assets which, as well as The Randox Grand National Festival, include the The Festival™ at Cheltenham, The Derby Festival at Epsom Downs and the National Stud, with all profits going back into the sport thanks to being a company incorporated by Royal Charter.
Dickon White, North West Regional Director for Jockey Club Racecourses, who runs Aintree, said:
“I am delighted that Randox has agreed to extend their sponsorship for the Grand National Festival for a further five years. It’s been a fantastic partnership over the past few years and we’ve been extremely impressed with their operation as well as their dedication to one of sports’ most iconic events.
“At a time when we are facing massive challenges in British racing, it is a tremendous boost to The Jockey Club, and a huge endorsement to the Grand National itself, that a new multi-year deal has been agreed with Randox.”
“The Randox Grand National continues to go from strength to strength and we look forward to working closely with Dr FitzGerald and his talented and committed team in the coming years.”
For further information please contact: Amy Millar – PR Team Leader on Amy.Millar@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox approved for COVID-19 test to release scheme
RANDOX approved for COVID-19 test to release
21 December 2020: RANDOX approved for COVID-19 test to release
Randox has been added to the Department of Health and Social Care’s list of private providers of coronavirus testing.
This includes the lists for both general testing and test to release, a scheme which is applicable to those in England who need to self-isolate on their return from international travel.
If after 5 days you take a test and receive a negative result, you can stop self-isolating.
To purchase your COVID-19 test kit for test to release, visit; https://www.randoxhealth.com/covid-19-home-testing-kit-2/
Please Note: The earliest you can take the test is 5 full days after you left the country not on the travel corridor list. Individuals who do not opt into the Test to Release scheme will need to self-isolate until 10 full days have passed since they were last in a country not on the travel corridors list.
To opt into the scheme, visit https://www.gov.uk/provide-journey-contact-details-before-travel-uk
You must complete this form within 48 hours of arriving back in the UK and will require your booking reference number and name of the test provider.
To view the list of test and release testing providers, visit; https://www.gov.uk/government/publications/list-of-private-providers-of-coronavirus-testing/list-of-private-providers-of-coronavirus-testing
It is important to keep up to date with government guidelines by visiting https://www.gov.uk/guidance/travel-advice-novel-coronavirus to find out more.
For further information please contact covidcustomersupport@randox.com
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TRAVEL CERTIFICATE
LABORATORY TOOLS
Randox launches Mobile COVID-19 Lab for Workplace Testing
Randox launches Mobile COVID-19 Lab for Workplace Testing
11 December 2020: Randox launches Mobile COVID-19 Lab for Workplace Testing
World-leading diagnostics company Randox Laboratories has today unveiled a new Mobile Laboratory Service which will offer rapid and reliable COVID-19 workplace testing.
The service from Randox, which is the largest COVID-19 testing provider in the UK and Ireland, and a partner in the UK Government’s National COVID-19 Testing Programme, uses gold standard PCR technology to generate results in 1 – 3 hours.
Each Mobile Laboratory will be capable of processing up to 1000 samples per day, to allow employers to uphold COVID safety within the workplace and maintain maximum output.
Dr Peter FitzGerald, Randox Managing Director, said;
“As the nation continues to navigate the working challenges caused by the COVID-19 pandemic, an increasing number of organisations will want to implement a COVID-19 testing regime so that they can sustain safe working environments.
“With this in mind we continue to expand our portfolio of bespoke testing products and services, and our latest addition, the Mobile Testing Laboratory, in conjunction with our work within the National Testing Programme, brings us one step closer to a timely return to a more normal society.”
As part of the Randox Mobile COVID-19 testing service, a team of healthcare professionals will collect the samples on site, and a Laboratory Technician will subsequently expedite the sample and reports the results.
The Mobile Laboratory is available across the UK from 14th December 2020.
Dr FitzGerald continued;
“Since a new study by researchers at the University College London revealed that 86% of people who tested positive for COVID-19 did not have virus symptoms1, frequent screening of asymptomatic patients, is vital to identify any hotspots and limit further spread.
“Our Mobile COVID-19 Laboratory, which uses gold standard PCR technology and can visit the location of your choice for immediate service, will promote safe working practices, allow companies to demonstrate their commitment to their staff, and facilitate recovery of the UK economy.”
The Randox Mobile COVID-19 Laboratory comes fully staffed and stocked for testing, and is suitable for any and all industries – Construction, Aviation, Hospitality, Retail and more.
Find out more at https://www.randoxhealth.com/mobile-covid-19-testing-laboratory/
For further information please email mobiletesting@randox.com
References
1 https://www.ucl.ac.uk/news/2020/oct/symptoms-covid-19-are-poor-marker-infection
Want to know more about Randox?
Contact us or visit our homepage to view more.